期刊文献+

甲状旁腺切除术对继发性甲状旁腺功能亢进症患者生活质量影响的研究进展 被引量:1

Research progress on the effect of parathyroidectomy on the quality of life in patients with secondary hyperparathyroidism
原文传递
导出
摘要 继发性甲状旁腺功能亢进(secondary hyperparathyroidism,SHPT)是长期透析患者常见的严重并发症,患者常经历多种症状,生活质量低下。针对药物治疗不佳的严重SHPT患者,甲状旁腺切除术(parathyroidectomy,PTX)是效果确切的优选方案。而目前,PTX术后随访工作尚未得到足够重视,对患者的临床症状及生活质量评估尚不充分。鉴于此,我们系统梳理患者术后生活质量和相关症状的变化情况及其影响因素,旨在为今后开展此类患者的症状管理实践和研究提供参考。 Secondary hyperparathyroidism(SHPT)is a common and serious complication in long-term dialysis patients,who often experience multiple symptoms and a poor quality of life.Parathyroidectomy(PTX)is the best choice for severe SHPT patients with poor drug treatment.At present,the follow-up after PTX has not received sufficient attention,and the assessment of patients'clinical symptoms and quality of life is not yet adequate.In view of this,we systematically combed the changes and influencing factors of patients'quality of life and related symptoms after surgery,in order to provide reference for the practice and research of symptom management of such patients in the future.
作者 周仕依 张伟 陈孜瑾 朱大乔 Zhou Shiyi;Zhang Wei;Chen Zijin;Zhu Daqiao(School of Nursing,Shanghai Jiao Tong University,Shanghai 200025,China;Department of Thyroid Breast and Hernia Surgery,Changzheng Hospital Affiliated to Navy Medical University,Shanghai 200003,China;Department of Nephrology,Ruijin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine,Shanghai 200025,China)
出处 《中国综合临床》 2022年第6期494-499,共6页 Clinical Medicine of China
基金 上海市卫生健康委员会研究项目(202140514) 上海高水平地方高校创新团队建设项目(SHSMU-ZDCX20212801) 上海交通大学医学院护理学科人才建设项目(KJ3-0230-21-2001)。
关键词 继发性甲状旁腺功能亢进症 甲状旁腺切除术 生活质量 症状 Secondary hyperparathyroidism Parathyroidectomy Quality of life Symptoms
  • 相关文献

参考文献17

二级参考文献135

  • 1姜鸿,徐志宏,张凌,宋韩明,李文歌.慢性肾脏病3~5期透析前患者矿物质及骨代谢紊乱的调查分析[J].中国血液净化,2012,11(7):360-364. 被引量:43
  • 2谢红浪,季大玺,徐斌,龚德华,任冰,刘芸,王华,张一丹,刘志红,黎磊石.1254例维持性血液透析患者长期生存分析[J].肾脏病与透析肾移植杂志,2005,14(2):136-141. 被引量:70
  • 3S Moe, T Dr u eke, J Cunningham, et al. Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)[J]. Kidney Int, 2006,69:1945-1953.
  • 4Sherrard D, Oh S, Maloney N, et al. Renal osteodystrophy: Classification, cause and treatment. In Frame BPJ, Jr, ed. Clinical disorders of bone and mineral metabolism Amsterdam: Excerpta Medica, 1983, 254-259.
  • 5Beatriz D, Kuizon IB, Salusky. Cell biology of renal osteodystrophy[J].Pediatr Nephrol, 2002,17:777-789.
  • 6Monier-Faugere MC, Malluche HH. Trends in renal osteodystrophy: a survey from 1983 to 1995 in a total of 2248 patients[J]. Nephrol Dial Tansplant, 1996,11 [Suppl 3]:111-120.
  • 7Gal-Moscovici A, Popovtzer MM. New worldwide trends in presentation of renal osteodystrophy and its relationship to parathyroid hormone levels[J]. Clin Nephrol, 2005,63(4):284-289.
  • 8Pei Y, Hercz G, Greenwood C, et al. Risk factors for renal osteodystrophy: a multivariant analysis[J]. J Bone Miner Res, 1995, 10:149-156.
  • 9Malluche HH, Monier Faugere MC. Risk of adynamic bone disease in dialyzed patients[J]. Kidney Int Suppl, 1992, 38:S62-S67.
  • 10Couttenye MM, D' aese PC, Deng JT, et al. High prevalence of adynamic bone disease diagnosed by biochemical markers in a wide sample of the European CAPD population[J]. Nephrol Dial Transplant, 1997, 12:2144- 2150.

共引文献235

同被引文献12

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部